Resource Library

The COVID-19 pandemic highlighted the importance of digital transformation. Today, life sciences organizations are writing a new chapter in the chronicles of transformation, thanks to artificial intelligence. With the average cost of developing a new drug at approximately $2.3 billion, streamlining and automating the clinical trial process is a perfect use case for AI. In this webcast from Modus Create, featuring a life sciences industry analyst from IDC, you’ll discover how AI and GenAI can transform the clinical trial process to improve clinical outcomes and accelerate time to market, using technologies and best practices like:

• AI-backed intelligent application development
• Employing discriminative (traditional) and generative models e.g. large language models (LLMs)
• Real-time collaboration
• Data preprocessing
• Impact, cost & ROI forecasting
• Data & AI governance